TFX as reported
Teleflex Incorporated reported $2.25B of revenue over the trailing twelve months, +31% on the year before. 11 reported series are charted on this page, each one as filed.
$2.25B
Revenue, trailing twelve months · to Q2 2026 · +31% against the twelve months before
- Net Income
- −$1.03B
Net Income · −638% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $168M
Free Cash Flow · +1434% year on year · trailing twelve months to Q2 2026
- Op Margin
- 2.0%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $2.25B | +31% | Q2 2026 |
| Net Income | −$1.03B | −638% | Q2 2026 |
| EPS | −$23.29 | −645% | Q2 2026 |
| Gross Margin | 55% | n/a | Q2 2026 |
| Op Margin | 2.0% | n/a | Q2 2026 |
| Net Margin | −45% | n/a | Q2 2026 |
| ROE | −26% | n/a | Q2 2026 |
| ROA | −12% | n/a | Q2 2026 |
| ROIC | 1.3% | n/a | Q2 2026 |
| Free Cash Flow | $168M | +1434% | Q2 2026 |
| P/E | 60.0 | n/a | Q2 2025 · 4 quarters behind |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Teleflex Incorporated (TFX) - Revenue & ProfitRevenue & ProfitTeleflex Incorporated (TFX)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #12 of 27 by Smart Score